FitMi AD Home Therapy for Alzheimer's Disease
Trial Summary
What is the purpose of this trial?
This study will investigate the efficacy of a newly developed exercise device (FitMi AD) for individuals with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's disease. FitMi AD uses embedded sensors that can track and record the patient's direction and degree of movement while performing exercises described on a computer.
Research Team
Freddi Segal-Gidan, PA, PhD
Principal Investigator
Rancho Research Institute, Inc.
Eligibility Criteria
This trial is for individuals over 50 with mild cognitive impairment or mild dementia due to Alzheimer's, who can see and hear well enough to follow on-screen instructions. They must have support from someone who knows about their daily living skills.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants perform exercises using either the FitMi AD device or a conventional exercise booklet for 3 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Conventional exercise program (Behavioural Intervention)
- FitMi AD Home Therapy (Procedure)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Flint Rehabilitation Devices, LLC
Lead Sponsor
Rancho Research Institute, Inc.
Collaborator